已核实 DOI PubMed 相关产品: 4

Conditionally designed luminescent DNA crystals doped by Ln3+(Eu3+/Tb3+) complexes or fluorescent proteins with smart drug sensing property

Journal 2022 · IF 7.571 · 10(34): 6443-6452 · 发表于 2022 年 6 月 8 日
作者: Dan Xiu,Sibo Zhao,Zhenhua Li,Yanan Xu,Yao Wang,Zhijun Zhu,Min Zhang,Christopher D. Snow,Laurence A. Belfiore,Jianguo Tang
阅读全文 在 PubMed 查看

摘要

In this work, a designed porous DNA crystal with high intrinsic biocompatibility was used as the scaffold material to load fluorescent guest molecules to detect anti-cancer drugs. It is shown here that the synthesized crystals have the characteristics consistent with the designed large solvent channels, and can therefore accommodate guest molecules such as fluorescent proteins that cannot be accommodated by less porous crystals. Eu(TTA)3phen and Tb(acac)3phen lanthanide complexes were individually noncovalently loaded into the porous crystals, resulting in hybrid luminescent DNA crystals. Emodin, an anti-cancer, anti-tumor, anti-inflammatory drug, was found to quench lanthanide complexes in solution or in crystals. Notably, emodin is the active ingredient of Lianhua Qingwen Capsule, an anti-COVID-19 drug candidate. Therefore, the porous DNA crystals reported here have potential applications as a biocompatible and theranostic delivery biomaterial for functional macromolecules.

本研究中使用的阿拉丁产品

4 款产品在本文中被引用